相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis
Mieke Gouwy et al.
PLOS ONE (2016)
Systematic single cell analysis of migration and morphological changes of human neutrophils over stimulus concentration gradients
Akira Yamauchi et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Francoise Bachelerie et al.
PHARMACOLOGICAL REVIEWS (2014)
Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial
Paul P. Tak et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The Chemokine Receptor CCR1 Is Constitutively Active, Which Leads to G Protein-independent, β-Arrestin-mediated Internalization
C. Taylor Gilliland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The biochemistry and biology of the atypical chemokine receptors
G. J. Graham et al.
IMMUNOLOGY LETTERS (2012)
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3
Sofie Struyf et al.
BLOOD (2011)
μ-Slide Chemotaxis: A new chamber for long-term chemotaxis studies
Pamela Zengel et al.
BMC CELL BIOLOGY (2011)
Molecular pathways of platelet factor 4/CXCL4 signaling
Brigitte Kasper et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes
Anna Korniejewska et al.
IMMUNOLOGY (2011)
CXCL4 Downregulates the Atheroprotective Hemoglobin Receptor CD163 in Human Macrophages
Christian A. Gleissner et al.
CIRCULATION RESEARCH (2010)
CXC Chemokine Receptor 4 Is a Cell Surface Receptor for Extracellular Ubiquitin
Vikas Saini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages
Christian A. Gleissner et al.
JOURNAL OF IMMUNOLOGY (2010)
Therapeutic targeting of chemokine interactions in atherosclerosis
Rory R. Koenen et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
An Improved Chamber for Direct Visualisation of Chemotaxis
Andrew J. Muinonen-Martin et al.
PLOS ONE (2010)
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice
Rory R. Koenen et al.
NATURE MEDICINE (2009)
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
Christophe Combadiere et al.
CIRCULATION (2008)
CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3
Anja Mueller et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Christian Weber et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device - TAXIScan
Nao Nitta et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice
Vincent Braunersreuther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Accelerated atherosclerosis in autoimmune rheumatic diseases
Y Shoenfeld et al.
CIRCULATION (2005)
Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist
FL de Mendonça et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
P von Hundelshausen et al.
BLOOD (2005)
Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells
LC Parker et al.
JOURNAL OF IMMUNOLOGY (2004)
Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients
O Pervushina et al.
JOURNAL OF IMMUNOLOGY (2004)
Variations in eosinophil chemokine responses: An investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter
RM Phillips et al.
JOURNAL OF IMMUNOLOGY (2003)
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4
L Lasagni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice
C Combadière et al.
CIRCULATION (2003)
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
YQ Huo et al.
NATURE MEDICINE (2003)
Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells
J Fleischer et al.
JOURNAL OF IMMUNOLOGY (2002)
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
BS Sachais et al.
BLOOD (2002)
The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b
R Martinelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A small molecule antagonist of chemokine receptors CCR1 and CCR3 - Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry
I Sabroe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
